Propanc Biopharma (PPCB) Tax Rate (2010 - 2024)
Propanc Biopharma (PPCB) posted quarterly Tax Rate of 0.07% for Q2 2024, up 23.0% year-over-year from 0.05% in Q3 2023, and up 26.57% quarter-over-quarter from 0.05% in Q1 2024.
Propanc Biopharma (PPCB) Tax Rate (2010 - 2024) Analysis & Trends
Propanc Biopharma (PPCB) has reported Tax Rate for 15 consecutive years, with 0.07% the latest figure, recorded in Q2 2024.
- In Q2 2024, Tax Rate rose 23.0% year-over-year to 0.07%; the TTM figure through Jun 2024 stood at 6.56% (up 192.0% YoY), while the FY2024 annual figure was 6.62%, up 197.0% from the prior year.
- Tax Rate grew to 0.07% in Q2 2024 per PPCB's latest filing, from 0.05% in the prior quarter.
- Across five years, Tax Rate topped out at 21.18% in Q1 2021 and bottomed at 0.16% in Q2 2023.
- Historically, Tax Rate has averaged 5.23% across 5 years, with a median of 0.15% in 2021.
- Annual changes were most pronounced in 2020 — Tax Rate slumped 6825 bps — and 2021, when it surged 2018 bps.
- Propanc Biopharma's Tax Rate stood at 0.03% in 2020, then surged by 22866 bps to 6.48% in 2021, then jumped by 224 bps to 21.04% in 2022, then fell by 14 bps to 18.04% in 2023, then plunged by 100 bps to 0.07% in 2024.
- Business Quant data shows PPCB's Tax Rate at 0.07% in Q2 2024, 0.05% in Q1 2024, and 18.04% in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.91% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 24.15% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 7.49% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -16.71% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 34.12% |
| 10 | Propanc Biopharma | 587,855.41 | 587,855.41 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 0.07% |
| Jun 30, 2024 | 0.07% |
| Jun 30, 2024 | 0.07% |
| Mar 31, 2024 | 0.05% |
| Mar 31, 2024 | 0.05% |
| Mar 31, 2024 | 0.05% |
| Dec 31, 2023 | 18.04% |
| Dec 31, 2023 | 18.04% |
| Dec 31, 2023 | 18.04% |
| Jun 30, 2023 | -0.16% |
| Jun 30, 2023 | -0.16% |
| Jun 30, 2023 | -0.16% |
| Mar 31, 2023 | 0.21% |
| Mar 31, 2023 | 0.21% |
| Mar 31, 2023 | 0.21% |
| Dec 31, 2022 | 21.04% |
| Dec 31, 2022 | 21.04% |
| Dec 31, 2022 | 21.04% |
| Jun 30, 2022 | -0.03% |
| Jun 30, 2022 | -0.03% |